Litcius/Paper detail

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

Sydney M. Shaffer, Margaret C. Dunagin, Stefan Torborg, Eduardo A. Torre, Benjamin Emert, Clemens Krepler, Marilda Beqiri, Katrin Sproesser, Patricia Brafford, Min Xiao, Elliott Eggan, Ioannis N. Anastopoulos, Cesar A. Vargas-García, Abhyudai Singh, Katherine L. Nathanson, Meenhard Herlyn, Arjun Raj

2017Nature1,309 citationsDOI

Topics & Concepts

ReprogrammingEpigeneticsTranscription factorBiologyDrug resistanceCancer cellCellGeneCell biologyCancer researchGeneticsCancerCancer Genomics and DiagnosticsCancer Cells and MetastasisCRISPR and Genetic Engineering
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance | Litcius